Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus F Rabe

Showing results (21-30 of 388) with videos related to

Pageof 39
Sort By:
Chest|May 7, 2014
Point: were industry-sponsored roflumilast trials appropriate? YesSamy Suissa, Klaus F Rabe
Deutsche Medizinische Wochenschrift (1946)|March 17, 2015
[Are disease management programs in Germany effective?]Andreas Ziegler, Klaus F Rabe
Lancet (London, England)|August 21, 2012
Uncovering and tackling Europe's hidden respiratory illnessKlaus F Rabe, Brian Ward
NEJM Evidence|July 22, 2025
Seize the Day - Early Detection of COPDMustafa Abdo, Klaus F Rabe
Lancet (London, England)|August 18, 2004
Burden and clinical features of chronic obstructive pulmonary disease (COPD)Romain A Pauwels, Klaus F Rabe
American Journal of Respiratory and Critical Care Medicine|May 17, 2013
Global Initiative on Obstructive Lung Disease revised: what constitutes a guideline?Klaus F Rabe, Christopher B Cooper
Lancet (London, England)|September 13, 2011
Controversies in treatment of chronic obstructive pulmonary diseaseKlaus F Rabe, Jadwiga A Wedzicha
Chest|January 10, 2026
ResponseSurya P Bhatt, Klaus F Rabe
Chest|October 7, 2010
Endosonography for lung cancer staging: one scope fits all?Jouke T Annema, Klaus F Rabe
American Journal of Respiratory and Critical Care Medicine|October 2, 2010
Theophylline for chronic obstructive pulmonary disease?....Time to move onKlaus F Rabe, P S Hiemstra
Pageof 39

Showing results (21-30 of 388) with videos related to

Sort By:
Pageof 39
Chest|May 7, 2014
Point: were industry-sponsored roflumilast trials appropriate? YesSamy Suissa, Klaus F Rabe
Deutsche Medizinische Wochenschrift (1946)|March 17, 2015
[Are disease management programs in Germany effective?]Andreas Ziegler, Klaus F Rabe
Lancet (London, England)|August 21, 2012
Uncovering and tackling Europe's hidden respiratory illnessKlaus F Rabe, Brian Ward
NEJM Evidence|July 22, 2025
Seize the Day - Early Detection of COPDMustafa Abdo, Klaus F Rabe
Lancet (London, England)|August 18, 2004
Burden and clinical features of chronic obstructive pulmonary disease (COPD)Romain A Pauwels, Klaus F Rabe
American Journal of Respiratory and Critical Care Medicine|May 17, 2013
Global Initiative on Obstructive Lung Disease revised: what constitutes a guideline?Klaus F Rabe, Christopher B Cooper
Lancet (London, England)|September 13, 2011
Controversies in treatment of chronic obstructive pulmonary diseaseKlaus F Rabe, Jadwiga A Wedzicha
Chest|January 10, 2026
ResponseSurya P Bhatt, Klaus F Rabe
Chest|October 7, 2010
Endosonography for lung cancer staging: one scope fits all?Jouke T Annema, Klaus F Rabe
American Journal of Respiratory and Critical Care Medicine|October 2, 2010
Theophylline for chronic obstructive pulmonary disease?....Time to move onKlaus F Rabe, P S Hiemstra
Pageof 39